Predictors of survival outcomes in patients with <i>MECOM EVI1</i> rearrangement aberrations in AML or MDS.Yael Kusne, Cecilia Ysabel Arana Yi, Katalin Kelemen et al.|Journal of Clinical Oncology|2023Cited by 3